The impact of thyroid autoantibodies on the cycle outcome and embryo quality in women undergoing intracytoplasmic sperm injection

TOKGÖZ V. Y., Isim B., TEKİN A. B.

MIDDLE EAST FERTILITY SOCIETY JOURNAL, cilt.25, sa.1, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1186/s43043-020-00023-6
  • Dergi Adı: MIDDLE EAST FERTILITY SOCIETY JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, Directory of Open Access Journals
  • Anahtar Kelimeler: Thyroid, Autoantibody, Autoimmunity, Intracytoplasmic sperm injection, Embryo quality, IN-VITRO FERTILIZATION, ANTITHYROID ANTIBODIES, EUTHYROID WOMEN, AUTOIMMUNITY, PREGNANCY, DISEASE, IVF, HYPOTHYROIDISM, IMPLANTATION, ASSOCIATION
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Background The influence of thyroid autoimmunity in in-vitro fertilization/intracytoplasmic sperm injection (ICSI) cycles is still a controversial issue. Although some women are euthyroid, some studies found thyroid dysfunction and thyroid autoimmunity increased the incidence of infertility. We aimed to evaluate the impact of anti-thyroid antibodies on the cycle parameters, embryo quality, and pregnancy outcomes in women who underwent ICSI cycles. Results Fertilization rate was significantly higher in anti-thyroid antibody-negative patients than in anti-thyroid antibody-positive patients (97.1 +/- 10.5 vs. 91.5 +/- 19.8, respectively, p = 0.003). Clinical pregnancy, miscarriage, and ongoing pregnancy rates were not different among study groups. The presence of top-quality embryo was lower in anti-thyroid antibody-positive patients but it did not reach any statistical significance (56.5% vs. 67.8%, p = 0.09). In the subgroup analysis, there were no significant differences except for the miscarriage rate according to the TSH threshold. Conclusion The clinical pregnancy and ongoing pregnancy were not affected by the positivity of anti-thyroid antibodies. We showed that thyroid autoimmunity may have an impact on fertilization rate and embryo quality in patients undergoing ICSI cycles. Miscarriage rate also increases with thyroid autoimmunity and TSH levels above 2.5 mu IU/L.